137 related articles for article (PubMed ID: 16142561)
1. Significance of the percentage of prostate needle biopsy cores with cancer as a predictor of disease extension in radical prostatectomy specimens in Japanese men.
Sakai I; Harada K; Hara I; Eto H; Miyake H
Int Urol Nephrol; 2005; 37(2):305-10. PubMed ID: 16142561
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy].
Ojea Calvo A; Núñez López A; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; Gómez-González MC; González Piñeiro A; Otero García M; Nogueira March JL
Actas Urol Esp; 2003 Jun; 27(6):428-37. PubMed ID: 12918149
[TBL] [Abstract][Full Text] [Related]
3. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy.
Antunes AA; Srougi M; Dall'Oglio MF; Crippa A; Campagnari JC; Leite KR
BJU Int; 2005 Dec; 96(9):1258-63. PubMed ID: 16287441
[TBL] [Abstract][Full Text] [Related]
4. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
5. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
6. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
[TBL] [Abstract][Full Text] [Related]
7. Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies.
Miyake H; Kurahashi T; Muramaki M; Yamanak K; Hara I
Int J Urol; 2005 Nov; 12(11):964-8. PubMed ID: 16351652
[TBL] [Abstract][Full Text] [Related]
8. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
[TBL] [Abstract][Full Text] [Related]
9. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877
[TBL] [Abstract][Full Text] [Related]
10. Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy.
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2004 Jun; 11(6):402-6. PubMed ID: 15157210
[TBL] [Abstract][Full Text] [Related]
11. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.
Elliott SP; Shinohara K; Logan SL; Carroll PR
J Urol; 2002 Jul; 168(1):105-9. PubMed ID: 12050501
[TBL] [Abstract][Full Text] [Related]
12. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
[TBL] [Abstract][Full Text] [Related]
13. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
[TBL] [Abstract][Full Text] [Related]
14. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
Poulos CK; Daggy JK; Cheng L
Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
[TBL] [Abstract][Full Text] [Related]
15. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
Epstein JI; Walsh PC; Sauvageot J; Carter HB
J Urol; 1997 Nov; 158(5):1886-90. PubMed ID: 9334623
[TBL] [Abstract][Full Text] [Related]
16. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
17. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
Makarov DV; Sanderson H; Partin AW; Epstein JI
J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
[TBL] [Abstract][Full Text] [Related]
18. Percentage of tumour-positive biopsy cores: an independent predictor of extraprostatic disease.
Mortensen MM; Mortensen PS; Borre M
Scand J Urol Nephrol; 2009; 43(2):109-13. PubMed ID: 19242861
[TBL] [Abstract][Full Text] [Related]
19. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
Villamón-Fort R; Martínez-Jabaloyas JM; Soriano-Sarriá P; Ramos-Soler D; Pastor-Hernández F; Gil-Salom M
Urol Int; 2007; 78(4):328-33. PubMed ID: 17495491
[TBL] [Abstract][Full Text] [Related]
20. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K
Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
